Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome

British Journal of Haematology

Volumn 118, Issue 1, 2002, Pages 151-156

  Verstovsek, Srdan ^a   Estey, Elihu ^a   Manshouri, Taghi ^a   Giles, Francis J ^a   Cortes, Jorge ^a   Beran, Miloslav ^a   Rogers, Anna ^a   Keating, Michael ^a   Kantarjian, Hagop ^a   Albitar, Maher ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

AML; MDS; Prognosis; VEGF; VEGF receptors

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN C;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION FUNCTION; EVALUATION; HUMAN; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; SAMPLING; SURVIVAL RATE;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; BONE MARROW; ENDOTHELIAL GROWTH FACTORS; HUMANS; LEUKEMIA, MYELOID; LYMPHOKINES; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036062374     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03551.x     Document Type: Article

References (21)

1. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms
2. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia
3. Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia
4. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
5. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies
6. FGF and VEGF function in angiogenesis: Signalling pathways, biological responses and therapeutic inhibition
7. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration
8. Molecular and biological properties of vascular endothelial growth factor
9. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia
10. Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia
11. Vascular endothelial growth factor at high plasma levels is associated with extranodal involvement in adult T cell leukemia patients
12. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor
13. Vascular endothelial growth factor is a secreted angiogenic mitogen
14. Numerous growth factors, cytokines, and chemokines are secreted by human CD34 (+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner
15. Angiogenesis and angiogenic mediators in haematological malignancies
16. Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia
17. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth
18. Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma
19. Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis
20. Regulation of angiogenesis via vascular endothelial growth factor receptors
21. Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat